Lykiri
8 minutes ago
Scolyer became the first patient in the world to undergo neoadjuvant (pre-surgery) triplet immunotherapy, receiving a combination of anti-CTLA-4, anti-PD-1, and anti-LAG-3 checkpoint inhibitors before tumor removal. He also received a personalized cancer vaccine, developed using genomic analysis of